Targeting programmed cell death in neurodegenerative diseases

Nat Rev Neurosci. 2003 May;4(5):365-75. doi: 10.1038/nrn1100.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / metabolism
  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Amyotrophic Lateral Sclerosis / genetics
  • Amyotrophic Lateral Sclerosis / metabolism
  • Animals
  • Apoptosis*
  • Dopamine Agents / metabolism
  • Humans
  • Huntington Disease / genetics
  • Huntington Disease / metabolism
  • Models, Biological
  • Neurodegenerative Diseases* / genetics
  • Neurodegenerative Diseases* / metabolism
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism

Substances

  • Dopamine Agents
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine